Fresenius SE EBITDA Margin 2016-2023 | FSNUY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fresenius SE (FSNUY) over the last 10 years. The current EBITDA margin for Fresenius SE as of September 30, 2023 is .
Fresenius SE EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-09-30 $39.20B $4.42B 11.27%
2023-06-30 $43.73B $6.23B 14.24%
2023-03-31 $43.10B $6.44B 14.95%
2022-12-31 $43.03B $6.63B 15.41%
2022-09-30 $43.53B $7.15B 16.42%
2022-06-30 $43.99B $7.49B 17.02%
2022-03-31 $44.47B $7.90B 17.77%
2021-12-31 $44.39B $8.08B 18.19%
2021-09-30 $44.08B $8.03B 18.21%
2021-06-30 $43.51B $8.20B 18.85%
2021-03-31 $42.19B $8.14B 19.29%
2020-12-31 $41.44B $8.11B 19.57%
2020-09-30 $40.66B $8.15B 20.05%
2020-06-30 $40.06B $7.99B 19.93%
2020-03-31 $40.09B $7.95B 19.84%
2019-12-31 $39.66B $7.93B 20.00%
2019-09-30 $39.42B $7.61B 19.31%
2019-06-30 $39.12B $7.27B 18.59%
2019-03-31 $39.27B $8.10B 20.64%
2018-12-31 $39.60B $7.89B 19.93%
2018-09-30 $39.76B $7.72B 19.41%
2018-06-30 $39.98B $7.90B 19.75%
2018-03-31 $39.37B $6.85B 17.40%
2017-12-31 $38.30B $6.81B 17.78%
2017-09-30 $36.47B $6.83B 18.71%
2017-06-30 $34.84B $6.56B 18.82%
2017-03-31 $33.47B $6.38B 19.07%
2016-12-31 $32.18B $6.09B 18.91%
2016-09-30 $31.71B $12.34B 38.92%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.537B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00